KBL Healthcare Ventures
19
22M
11
2
0.42
10
- Stages of investment
- Areas of investment
Summary
The venture was found in North America in United States. The main department of described VC is located in the New York.
The standard case for the fund is to invest in rounds with 6-7 partakers. Despite the KBL Healthcare Ventures, startups are often financed by ONSET Ventures, Investor Growth Capital Limited, Three Arch Partners. The meaningful sponsors for the fund in investment in the same round are ONSET Ventures, Investor Growth Capital Limited, InterWest Partners. In the next rounds fund is usually obtained by Three Arch Partners, ONSET Ventures, Investor Growth Capital Limited.
The fund is constantly included in less than 2 deals per year. The common things for fund are deals in the range of 10 - 50 millions dollars. When the investment is from KBL Healthcare Ventures the average startup value is 10-50 millions dollars. The important activity for fund was in 2000. The higher amount of exits for fund were in 2012. The real fund results show that this VC is 13 percentage points less often commits exit comparing to other companies. Opposing the other organizations, this KBL Healthcare Ventures works on 24 percentage points more the average amount of lead investments.
We also calculated 4 valuable employees in our database.
Among the most popular portfolio startups of the fund, we may highlight EpiCept Corporation, EpiCept Corporation, Remon Medical Technologies. Among the most popular fund investment industries, there are Consumer, Biotechnology. The fund has no exact preference in some founders of portfolio startups. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.
Investments analytics
Analytics
- Total investments
- 19
- Lead investments
- 2
- Exits
- 10
- Follow on index
- 0.42
- Investments by industry
- Health Care (18)
- Biotechnology (13)
- Medical Device (10)
- Medical (7)
- Therapeutics (5) Show 9 more
- Investments by region
-
- United States (17)
- Israel (2)
- Peak activity year
- 2005
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 28
- Avg. valuation at time of investment
- 72M
- Group Appearance index
- 0.95
- Avg. company exit year
- 17
- Avg. multiplicator
- 0.92
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
Avalon Pharmaceuticals | 17 Dec 2001 | Biotechnology, Health Care, Clinical Trials | Early Stage Venture | 70M | United States, Maryland, Germantown |
EpiCept Corporation | 01 Jan 2000 | Information Technology | Early Stage Venture | 4M | United States, New Jersey |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.